GD-40与其他β-内酰胺酶抑制剂对TEM-1和SHV-2β-内酰胺酶的体外活性比较 - Suppr | 超能文献

Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases.

作者信息

Danelon G, Mascaretti O, Radice M, Power P, Calcagno M L, Mata E G, Gutkind G

出版信息

J Antimicrob Chemother. 1998 Feb;41(2):313-5. doi: 10.1093/jac/41.2.313.

DOI:10.1093/jac/41.2.313

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases.GD-40与其他β-内酰胺酶抑制剂对TEM-1和SHV-2β-内酰胺酶的体外活性比较

J Antimicrob Chemother. 1998 Feb;41(2):313-5. doi: 10.1093/jac/41.2.313.

2

Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.棒酸、舒巴坦和他唑巴坦对临床重要β-内酰胺酶的比较活性。

Antimicrob Agents Chemother. 1994 Apr;38(4):767-72. doi: 10.1128/AAC.38.4.767.

3

Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence.他唑巴坦、舒巴坦和克拉维酸与SHV-1β-内酰胺酶反应形成的不同中间产物群体：拉曼晶体学证据。

J Am Chem Soc. 2009 Feb 18;131(6):2338-47. doi: 10.1021/ja808311s.

4

In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.β-内酰胺酶抑制剂克拉维酸、舒巴坦和他唑巴坦单独或与β-内酰胺类联合应用对经流行病学特征分析的多重耐药鲍曼不动杆菌菌株的体外活性。

Antimicrob Agents Chemother. 2004 May;48(5):1586-92. doi: 10.1128/AAC.48.5.1586-1592.2004.

5

Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.天冬氨酸替代276位的天冬酰胺会降低SHV-1和SHV-5β-内酰胺酶对基于机制的抑制剂的敏感性。

J Antimicrob Chemother. 1999 Jan;43(1):23-9. doi: 10.1093/jac/43.1.23.

6

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.β-内酰胺酶抑制剂YTR 830、克拉维酸和舒巴坦分别与氨苄西林和哌拉西林联合应用对产β-内酰胺酶厌氧菌的比较活性

J Chemother. 1989 Jul;1(4 Suppl):273-5.

7

Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases.pH对新型β-内酰胺酶及β-内酰胺酶抑制剂针对这些β-内酰胺酶活性的影响。

Antimicrob Agents Chemother. 1995 Aug;39(8):1856-8. doi: 10.1128/AAC.39.8.1856.

8

Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.探讨β-内酰胺酶抑制剂和碳青霉烯类药物对 CTX-M-9 的抑制作用。

Antimicrob Agents Chemother. 2011 Jul;55(7):3465-75. doi: 10.1128/AAC.00089-11. Epub 2011 May 9.

9

Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.了解SHVβ-内酰胺酶对β-内酰胺类和β-内酰胺酶抑制剂的耐药性：丝氨酸130诱变的启示

J Biol Chem. 2003 Dec 26;278(52):52724-9. doi: 10.1074/jbc.M306059200. Epub 2003 Oct 8.

10

Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.他唑巴坦是一种对特定的耐抑制剂A类β-内酰胺酶有效的抑制剂。

FEMS Microbiol Lett. 1997 Mar 1;148(1):59-62. doi: 10.1111/j.1574-6968.1997.tb10267.x.

引用本文的文献

1

The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.β-内酰胺类抗生素针对β-内酰胺酶的演变而发展。

Pharm Res. 2001 Oct;18(10):1391-9. doi: 10.1023/a:1012272403776.